Around the world, the prevalence of myopia is increasing at an alarming rate, due to a host of factors, including such as excessive near work and time spent indoors.
Beyond the daily burden of needing glasses, myopia, or near-sightedness, significantly increases the risk of permanently blinding ocular diseases, such as retinal detachment and myopic maculopathy. In addition, the prevalence of myopia is increasing worldwide at an alarming pace, currently effecting 33% of the world’s population and expected to reach 52% in 2050 (World Health Organization, 2015).
Existing therapeutic interventions have shown significant, but limited, clinical success in slowing the rate of childhood eye growth to combat myopic progression. Clerio Vision is exploring the interaction between the eye’s optics and neural system to develop novel, personalized contact lenses as a therapy for myopic progression.